The need to change the method for defining mild airway obstruction

European Respiratory Journal

Volumn 37, Issue 3, 2011, Pages 720-722

  Quanjer, P H ^a   Enright, P L ^b   Miller, M R ^c   Stocks, J ^d   Ruppel, G ^e   Swanney, M P ^f   Crapo, R O ^g   Pedersen, O F ^h   Falaschetti, E ⁱ   Schouten, J P ^j   Jensen, R L ^g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^f CHRISTCHURCH HOSPITAL   (New Zealand)

^g UNIVERSITY OF UTAH   (United States)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ERROR; ELDERLY CARE; FALSE NEGATIVE RESULT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; NOMENCLATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPIROMETRY;

ADULT; AIRWAY OBSTRUCTION; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; SOCIETIES, MEDICAL;

EID: 79953721449     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00135110     Document Type: Letter

References (40)

1. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flow. Eur Respir J 1993; 6: Suppl. 16, 5-40. (Pubitemid 23116782)
2. Falaschetti E, Laiho Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004; 23: 456-463. (Pubitemid 38344386)
3. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages. A new approach. Am J Respir Crit Care Med 2008; 177: 253-260. (Pubitemid 351198367)
4. www.spirxpert.com/GOLD.html, downloading the software gives access to over 80 sets of prediction equations and over 50,000 data demonstrating how the GOLD criteria lead to under diagnosis in young subjects and over diagnosis in those over 50 yrs.
5. www.spirxpert.com/controversies/controversy.html explains why the use of a fixed ratio is flawed.
6. Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J 2010; 36: 12-19.
7. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-1120.
8. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273. (Pubitemid 36986996)
9. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006; 130: 200-206. (Pubitemid 44116860)
10. Aggarwal AN, Gupta D, Behera D, et al. Comparison of fixed percentage method and lower confidence limits for defining limits of normality for interpretation of spirometry. Respir Care 2006; 51: 737-743. (Pubitemid 47109295)
11. 1/ FVC. Am J Respir Crit Care Med 2007; 176: 101-102.
12. Miller MR. What defines abnormal lung function? Thorax 2007; 62: 1107.
13. Petsonk EL, Hnizdo E, Attfield M. Definition of COPD GOLD stage I. Thorax 2007; 62: 1107-1108.
14. 1/FVC <70% as a criterion for COPD? Respir Med 2007; 101: 1097-1105.
15. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007; 30: 232-239.
16. Vollmer WM, Gíslason B, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
17. Miller MR, Pedersen OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? Eur Respir J 2009; 34: 527-528.
18. 1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
19. Olofson J, Bake B, Tengelin MN, et al. COPD 'diagnosis' based on spirometric reference equations. Clin Respir J 2008; 2: 214-219.
20. Ko FWS, Woo J, Tam W, et al. Prevalence and risk factors of airflow obstruction in an elderly Chinese population. Eur Respir J 2008; 32: 1472-1478.
21. Lau AC, Ip MS, Lai CK, et al. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 2008; 133: 42-48.
22. Schermer TR, Smeele IJ, Thoonen BP, et al. Current clinical guideline definitions for airflow obstruction leads to substantial overdiagnosis of COPD in primary care. Eur Respir J 2008; 32: 945-952.
23. Levy ML, Quanjer PH, Booker R, et al. Diagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J 2009; 18: 130-147.
24. Schermer TRJ, Quanjer PH. COPD screening in primary care: who is sick? Prim Care Respir J 2007; 16: 49-53.
25. Pérez-Padilla R, Hallal PC, Vázquez-García JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4: 113-120. (Pubitemid 47164863)
26. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of forced expiratory volume in 1-second to forced vital capacity as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
27. Miller MR, Quanjer PH, Swanney MP, et al. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011; 139: 52-59.
28. Enright PL. GOLD stage I is not a COPD risk factor. Thorax 2007; 62: 1107. (Pubitemid 350206207)
29. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
30. ATS Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
31. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
32. Townsend MC. Conflicting definitions of airways obstruction: drawing the line between normal and abnormal. Chest 2007; 131: 335-336. (Pubitemid 46280386)
33. Kerstjens HAM. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 212-213.
34. Enright P, Quanjer P. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator. COPD 2007; 4: 89-90. (Pubitemid 47164865)
35. Culver BH. Interpretation of spirometry: we can do better than the GOLD standard. Editorial. Respir Care 2006; 51: 719-721. (Pubitemid 47109291)
36. Wilt T, Niewoehner DE, Kim C-B, et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evidence report/technology assessment no. 121. (Prepared by the Minnesota Evidence-based Practice Center under contract no. 290-02-0009.) AHRQ Publication No. 05-E017-2. Rockville, Agency for Healthcare Research and Quality, 2005.
37. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3: 1-6.
38. Hansen JE, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction. Use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007; 131: 349-355.
39. Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.
40. Cerveri I, Corsico AG, Accordini S, et al. What defines airflow obstruction in asthma? Eur Respir J 2009; 34: 568-573.